02.05.2016
- AstraZeneca has agreed to grant exclusive rights for its Zurampic gout treatment in the US to partner Ironwood Pharmaceuticals. Zurampic was approved by the US Food and Drug...
05.01.2016
- Swedish drugmaker AstraZeneca has gained approval from the US Food and Drug Administration (FDA) to market Zurampic, a treatment for gout, the debilitating form of inflammatory...
